Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia

Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2013
Hauptverfasser: Janisch, Yu.V., Artamonova, A.B., Shlyakhovenko, V.A.
Format: Artikel
Sprache:Englisch
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/145248
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862748808719368192
author Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
author_facet Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
citation_txt Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats. Glycopeptide cancer vaccine prepared from P-388 leukemia cells, was immobilized of RC. ζ-potential of thymocytes from tumor-bearing mice was calculated from Smoluchowski equation. Results: The data have demonstrated the principal possibility of using the fragments of reconstructed chromatin of heterologous origin as a carrier of glycopeptide cancer vaccine prepared from the cells of P-388 leukemia. Preventive immunization with the correspondingly immobilized vaccine normalized ζ-potential of thymocytes in animals with transplanted P‑388 leukemia. Conclusions: The use of immobilization of glycopeptide cancer vaccine on reconstructed chromatin improves anticancer activity of the vaccination.
first_indexed 2025-12-07T20:56:55Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-145248
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T20:56:55Z
publishDate 2013
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
2019-01-19T21:09:53Z
2019-01-19T21:09:53Z
2013
Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia / Yu.V. Janisch, A.B. Artamonova, V.A. Shlyakhovenko // Experimental Oncology. — 2013. — Т. 35, № 3. — С. 198-201. — Бібліогр.: 10 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145248
Aim: To increase the effectiveness of anticancer vaccine delivery and activity via its immobilization on reconstructed chromatin (RC). Materials and Methods: The hybrid mice of CDF-1 line with transplanted P-388 leukemia were used. Reconstructed chromatin was obtained from the thymus of inbred rats. Glycopeptide cancer vaccine prepared from P-388 leukemia cells, was immobilized of RC. ζ-potential of thymocytes from tumor-bearing mice was calculated from Smoluchowski equation. Results: The data have demonstrated the principal possibility of using the fragments of reconstructed chromatin of heterologous origin as a carrier of glycopeptide cancer vaccine prepared from the cells of P-388 leukemia. Preventive immunization with the correspondingly immobilized vaccine normalized ζ-potential of thymocytes in animals with transplanted P‑388 leukemia. Conclusions: The use of immobilization of glycopeptide cancer vaccine on reconstructed chromatin improves anticancer activity of the vaccination.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
Article
published earlier
spellingShingle Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
Janisch, Yu.V.
Artamonova, A.B.
Shlyakhovenko, V.A.
Original contributions
title Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_full Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_fullStr Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_full_unstemmed Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_short Glycopeptide vaccine on DNA-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
title_sort glycopeptide vaccine on dna-histone carrier and its impact on ζ-potential of effector cells during experimental treatment of lymphoblastic leukemia
topic Original contributions
topic_facet Original contributions
url https://nasplib.isofts.kiev.ua/handle/123456789/145248
work_keys_str_mv AT janischyuv glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia
AT artamonovaab glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia
AT shlyakhovenkova glycopeptidevaccineondnahistonecarrieranditsimpactonζpotentialofeffectorcellsduringexperimentaltreatmentoflymphoblasticleukemia